Active Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In Situ
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA: The Journal of the American Medical Association
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Active Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In Situ: The COMET Randomized Clinical Trial
JAMA 2024 Dec 12;[EPub Ahead of Print], ES Hwang, T Hyslop, T Lynch, MD Ryser, A Weiss, A Wolf, K Norris, M Witten, L Grimm, S Schnitt, S Badve, R Factor, E Frank, D Collyar, D Basila, D Pinto, MA Watson, R West, L Davies, JL Donovan, A Shimada, Y Li, Y Li, AV Bennett, S Rosenberg, J Marks, E Winer, M Boisvert, A Giuliano, KE Larson, K Yost, PF McAuliffe, A Krie, N Tamirisa, LA Carey, AM Thompson, AH PartridgeFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.